Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4883 Target Snapshot

Urokinase plasminogen activator surface receptor · SINGLE PROTEIN · Homo sapiens

120Compounds
20Assays
4Approved Drugs
109.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q03405. Use UniProt Q03405 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q03405 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Urokinase plasminogen activator surface receptor as ChEMBL target CHEMBL4883, mapped to UniProt Q03405. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Urokinase plasminogen activator surface receptor
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4883
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q03405
Urokinase plasminogen activator surface receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Urokinase plasminogen activator surface receptor is the right protein anchor across sources, using UniProt Q03405 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelUrokinase plasminogen activator surface receptor
UniProt AccessionQ03405
Component TypeProtein
Sequence Length335 aa

Urokinase plasminogen activator surface receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Urokinase plasminogen activator surface receptor, mapped to UniProt Q03405. Sequence length is 335 aa.

Mapped IDQ03405
Review nameUrokinase plasminogen activator surface receptor
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

4
Approved
Assay Mix

Activity Type Distribution

IC5078.0
KI24.0
KD7.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2206698 10.96 Ki 0.011 Preclinical
CHEMBL2206697 10.92 Ki 0.012 Preclinical
CHEMBL2206687 10.48 Ki 0.0333 Preclinical
CHEMBL2206686 9.53 Ki 0.296 Preclinical
CHEMBL2206682 8.88 Ki 1.33 Preclinical
CHEMBL1652555 7.68 Ki 20.8 Preclinical
CHEMBL412236 7.4 IC50 40.0 Preclinical
CHEMBL405302 7.3 IC50 50.0 Preclinical
CHEMBL405999 7.22 IC50 60.0 Preclinical
CHEMBL263158 7.1 IC50 80.0 Preclinical
Distribution

pChEMBL Value Distribution

15
5.0
2
5.5
4
6.0
2
6.5
4
7.0
1
7.5
0
8.0
1
8.5
0
9.0
1
9.5
pChEMBL
Assay Landscape

Assay Landscape

20
Total Assays
67
Tested Compounds
1
Assay Types
Binding — 20 assays, 67 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 10 50 6.1
cell-based format 9 16 5.0
tissue-based format 1 1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine